Victory Capital Management Inc. Reduces Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Victory Capital Management Inc. lowered its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 92.4% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 13,578 shares of the company’s stock after selling 164,344 shares during the quarter. Victory Capital Management Inc.’s holdings in Nu Skin Enterprises were worth $143,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of NUS. Signaturefd LLC increased its stake in Nu Skin Enterprises by 72.6% during the 2nd quarter. Signaturefd LLC now owns 3,797 shares of the company’s stock valued at $40,000 after purchasing an additional 1,597 shares in the last quarter. CWM LLC increased its position in shares of Nu Skin Enterprises by 38.4% in the 1st quarter. CWM LLC now owns 3,286 shares of the company’s stock valued at $45,000 after acquiring an additional 911 shares during the period. Public Employees Retirement System of Ohio raised its stake in Nu Skin Enterprises by 30.5% in the 1st quarter. Public Employees Retirement System of Ohio now owns 3,926 shares of the company’s stock worth $54,000 after acquiring an additional 918 shares during the last quarter. Covestor Ltd grew its stake in Nu Skin Enterprises by 90.1% during the 1st quarter. Covestor Ltd now owns 4,353 shares of the company’s stock valued at $60,000 after purchasing an additional 2,063 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Nu Skin Enterprises by 167.4% in the second quarter. GAMMA Investing LLC now owns 5,734 shares of the company’s stock valued at $60,000 after purchasing an additional 3,590 shares during the period. 82.84% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Stock Down 4.0 %

Nu Skin Enterprises stock opened at $6.93 on Wednesday. The business’s 50-day moving average price is $9.26 and its 200 day moving average price is $11.33. The company has a quick ratio of 1.33, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. The firm has a market cap of $344.19 million, a price-to-earnings ratio of -115.50 and a beta of 1.13. Nu Skin Enterprises, Inc. has a 52 week low of $6.72 and a 52 week high of $23.19.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. The business had revenue of $439.10 million for the quarter, compared to analysts’ expectations of $431.87 million. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The business’s revenue was down 12.2% on a year-over-year basis. During the same quarter last year, the company earned $0.54 EPS. As a group, sell-side analysts anticipate that Nu Skin Enterprises, Inc. will post 0.78 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 11th. Shareholders of record on Friday, August 30th were issued a $0.06 dividend. The ex-dividend date was Friday, August 30th. This represents a $0.24 dividend on an annualized basis and a yield of 3.46%. Nu Skin Enterprises’s payout ratio is -400.00%.

Analyst Ratings Changes

A number of equities research analysts recently commented on NUS shares. Citigroup decreased their target price on Nu Skin Enterprises from $14.00 to $11.50 and set a “neutral” rating for the company in a report on Friday, August 9th. DA Davidson decreased their price objective on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a research note on Monday, August 12th. Finally, StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Friday, September 6th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Nu Skin Enterprises has a consensus rating of “Hold” and a consensus price target of $16.50.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.